Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Merck’s Welireg combo nabs FDA nod to expand kidney cancer reach
Analysts have projected rapid uptake for Welireg in second-line kidney cancer based on data from a phase 3 trial and doctors’ feedback.
Angus Liu
Sep 25, 2026 11:30am
Lundbeck relocating US headquarters to Boston in innovation move
Sep 25, 2026 10:41am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
Fierce Pharma Week: Top trends, campaigns and conversations
Sep 25, 2026 9:53am
Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay
Brought to you by
Bayer
Lilly-InnoCare, Elevar, China's 5-year plan—Fierce Pharma Asia
Sep 25, 2026 9:38am
